Trial
NCT04510584
Maintenance Treatment With Bevacizumab and Atezolizumab for Ovarian Cancer
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University Health Network, Toronto
Collaborators
—
Condition
Ovarian Endometrioid Tumor
Intervention
Atezolizumab
Why stopped
19 patients screenfailed, stopping recruitment before first patient enrollment to analyze pilot results from screening samples.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-06-06